查詢結果分析
來源資料
相關文獻
- Double Primary Pulmonary Adenocarcinomas with Different Morphological Subtypes and Different Anaplastic Lymphoma Kinase Expression in a 47-year-old Never-smoking Woman--A Case Report
- 小分子抑制劑調控間變性淋巴瘤激酶的結構變化
- 進展性非小細胞肺癌標靶治療新趨勢
- Anaplastic Lymphoma Kinase (ALK) Inhibitors: New Cancer Breakthroughs for Lung Cancer
- A Young Adult with Primary Signet Ring Cell Carcinoma of the Lung: A Case Report and Literature Review
- Crizotinib Treatment Failure in a Patient with Positive ALK-rearranged Advanced-stage Squamous Cell Lung Cancer--Case Report and Literature Review
- Delayed Photosensitivity Dermatitis Caused by Crizotinib
- ALK陽性晚期非小細胞肺癌的治療
頁籤選單縮合
題 名 | Double Primary Pulmonary Adenocarcinomas with Different Morphological Subtypes and Different Anaplastic Lymphoma Kinase Expression in a 47-year-old Never-smoking Woman--A Case Report=雙重原發性肺腺癌呈現不同之組織型態表現及不同間變性淋巴瘤激酶表現在一位47歲的非吸菸女性--案例報告 |
---|---|
作 者 | 潘奕宏; 楊志仁; 李瑞英; 林智鴻; 黃明賢; | 書刊名 | 胸腔醫學 |
卷 期 | 33:6 2018.12[民107.12] |
頁 次 | 頁242-248 |
分類號 | 415.468 |
關鍵詞 | 多發性肺癌; 間變性淋巴瘤激酶; Multiple primary lung cancer; ALK; Anaplastic lymphoma kinase; |
語 文 | 英文(English) |